Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Disease due to Mycobacterium avium-intracellulare.

× No keyword cloud information.

17 in total

Review 1. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors: Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal: Clin Microbiol Rev Date: 2012-07 Impact factor: 26.132

Review 2. Antigens of the Mycobacterium avium, Mycobacterium intracellulare complex.

Authors: S L Morris
Journal: Eur J Epidemiol Date: 1991-07 Impact factor: 8.082

Review 3. Susceptibility testing of Mycobacterium avium complex isolates.

Authors: L Heifets
Journal: Antimicrob Agents Chemother Date: 1996-08 Impact factor: 5.191

4. Enhanced intramacrophage activity of resorcinomycin A against Mycobacterium avium-Mycobacterium intracellulare complex after liposome encapsulation.

Authors: R Gomez-Flores; R Hsia; R Tamez-Guerra; R T Mehta
Journal: Antimicrob Agents Chemother Date: 1996-11 Impact factor: 5.191

5. Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

Authors: D K Blanchard; M B Michelini-Norris; C A Pearson; S McMillen; J Y Djeu
Journal: Infect Immun Date: 1991-07 Impact factor: 3.441

6. Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice.

Authors: N Düzgüneş; V K Perumal; L Kesavalu; J A Goldstein; R J Debs; P R Gangadharam
Journal: Antimicrob Agents Chemother Date: 1988-09 Impact factor: 5.191

Review 7. The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections.

Authors: G W Amsden; C A Peloquin; S E Berning
Journal: Drugs Date: 1997-07 Impact factor: 9.546

Review 8. Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome.

Authors: L B Barradell; G L Plosker; D McTavish
Journal: Drugs Date: 1993-08 Impact factor: 9.546

Review 9. The Mycobacterium avium complex.

Authors: C B Inderlied; C A Kemper; L E Bermudez
Journal: Clin Microbiol Rev Date: 1993-07 Impact factor: 26.132

10. Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-alpha) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex.

Authors: K Suzuki; W J Lee; T Hashimoto; E Tanaka; T Murayama; R Amitani; K Yamamoto; F Kuze
Journal: Clin Exp Immunol Date: 1994-10 Impact factor: 4.330